ATE260989T1 - Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen - Google Patents

Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen

Info

Publication number
ATE260989T1
ATE260989T1 AT98964070T AT98964070T ATE260989T1 AT E260989 T1 ATE260989 T1 AT E260989T1 AT 98964070 T AT98964070 T AT 98964070T AT 98964070 T AT98964070 T AT 98964070T AT E260989 T1 ATE260989 T1 AT E260989T1
Authority
AT
Austria
Prior art keywords
insights
search
active ingredients
genome research
novel active
Prior art date
Application number
AT98964070T
Other languages
English (en)
Inventor
David J Lockhart
Lisa Wodicka
Ming Hsui Ho
Original Assignee
Affymetrix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affymetrix Inc filed Critical Affymetrix Inc
Application granted granted Critical
Publication of ATE260989T1 publication Critical patent/ATE260989T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6834Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
AT98964070T 1997-12-19 1998-12-18 Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen ATE260989T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6828997P 1997-12-19 1997-12-19
PCT/US1998/026925 WO1999032660A1 (en) 1997-12-19 1998-12-18 Exploiting genomics in the search for new drugs

Publications (1)

Publication Number Publication Date
ATE260989T1 true ATE260989T1 (de) 2004-03-15

Family

ID=22081628

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98964070T ATE260989T1 (de) 1997-12-19 1998-12-18 Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen

Country Status (6)

Country Link
US (3) US6333155B1 (de)
EP (1) EP1040204B1 (de)
AT (1) ATE260989T1 (de)
AU (1) AU1926899A (de)
DE (1) DE69822206T2 (de)
WO (1) WO1999032660A1 (de)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143557A (en) * 1995-06-07 2000-11-07 Life Technologies, Inc. Recombination cloning using engineered recombination sites
US6720140B1 (en) 1995-06-07 2004-04-13 Invitrogen Corporation Recombinational cloning using engineered recombination sites
US6165709A (en) 1997-02-28 2000-12-26 Fred Hutchinson Cancer Research Center Methods for drug target screening
EP1025217B1 (de) 1997-10-24 2006-10-04 Invitrogen Corporation Rekombinatorisches klonieren unter verwendung von nukleinsaüren mit rekombinationsstellen
US7351578B2 (en) 1999-12-10 2008-04-01 Invitrogen Corp. Use of multiple recombination sites with unique specificity in recombinational cloning
US20030124555A1 (en) * 2001-05-21 2003-07-03 Invitrogen Corporation Compositions and methods for use in isolation of nucleic acid molecules
US6593084B2 (en) 1998-10-13 2003-07-15 Robert E. Bird Carcinogen assay
EP1173460B1 (de) 1999-03-02 2009-09-16 Life Technologies Corporation Zubereitungen und methoden zur verwendung in rekombinatorischem klonen von nukleinsäuren
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7244559B2 (en) 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
EP1283904A2 (de) * 1999-11-03 2003-02-19 Oncotech, Inc. Diagnose von krebs mit zellsortierung und genexpressionsprofilen
NZ539430A (en) * 1999-12-10 2006-09-29 Invitrogen Corp Use of multiple recombination sites with unique specificity in recombinational cloning
US7829313B2 (en) 2000-03-24 2010-11-09 Eppendorf Array Technologies Identification and quantification of a plurality of biological (micro)organisms or their components
US8288128B2 (en) 2004-11-18 2012-10-16 Eppendorf Array Technologies S.A. Real-time quantification of multiple targets on a micro-array
US7157227B2 (en) * 2000-03-31 2007-01-02 University Of Louisville Research Foundation Microarrays to screen regulatory genes
EP1268858A1 (de) * 2000-03-31 2003-01-02 Memorec Stoffel GmbH Medizinisch-Molekulare Entwicklung Verwendung von partikeln, die signalgebende eigenschaften und mindestens eine affinitätsgruppierung für markierte nukleinsäuren besitzen
US7244560B2 (en) * 2000-05-21 2007-07-17 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6743583B2 (en) * 2000-07-14 2004-06-01 The Board Of Trustees Of The Leland Stanford Junior University Identification of drugs and drug targets by detection of the stress response
WO2002006834A2 (en) * 2000-07-19 2002-01-24 Pointilliste, Inc. Nested sorting and high throughput screening
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6998234B2 (en) * 2000-11-03 2006-02-14 Oncotech, Inc. Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells
CA2447357A1 (en) 2001-05-22 2002-11-28 Gene Logic, Inc. Molecular toxicology modeling
WO2003004690A2 (en) * 2001-07-06 2003-01-16 454$m(3) CORPORATION Method for isolation of independent, parallel chemical micro-reactions using a porous filter
US7447594B2 (en) 2001-07-10 2008-11-04 Ocimum Biosolutions, Inc. Molecular cardiotoxicology modeling
US20030054396A1 (en) * 2001-09-07 2003-03-20 Weiner Michael P. Enzymatic light amplification
US6902921B2 (en) 2001-10-30 2005-06-07 454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US20050124022A1 (en) * 2001-10-30 2005-06-09 Maithreyan Srinivasan Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6956114B2 (en) 2001-10-30 2005-10-18 '454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
WO2003062402A2 (en) * 2002-01-24 2003-07-31 Pointilliste, Inc. Use of collections of binding sites for sample profiling and other applications
US20030195431A1 (en) * 2002-04-10 2003-10-16 Sukhatme Vikas P. Observation of effects of body fluids on indicator cells for disease diagnosis
EP1546383A4 (de) * 2002-09-17 2006-08-30 Pharmacia Corp Isolierung genetischer moleküle aus einem komplexen biologischen konstrukt zur verwendung bei der genetischen expressionsanalyse
US7364846B2 (en) * 2002-10-11 2008-04-29 Molecular Devices Corporation Gene expression profiling from FFPE samples
US7781163B2 (en) 2003-01-08 2010-08-24 Lesley Davenport G-quadruplex binding assays and compounds therefor
US7575865B2 (en) 2003-01-29 2009-08-18 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
CA2513899C (en) 2003-01-29 2013-03-26 454 Corporation Methods of amplifying and sequencing nucleic acids
AU2003212136A1 (en) * 2003-03-07 2004-09-28 National Research Council Of Canada The determination of function of mammalian proteins by analysis of global gene expression profiles
WO2004090161A1 (en) 2003-04-14 2004-10-21 Novartis Ag Gene expression associated with osteoblast differentiation
US20050009059A1 (en) * 2003-05-07 2005-01-13 Affymetrix, Inc. Analysis of methylation status using oligonucleotide arrays
CA2528536A1 (en) 2003-06-06 2005-01-06 Arborgen, Llc. Transcription factors
WO2005001051A2 (en) 2003-06-06 2005-01-06 Arborgen Llc. Compositions and methods for regulating polysaccharides of a plant cell
US20050064462A1 (en) * 2003-06-17 2005-03-24 Bernd Stein Methods, compositions, and kits for predicting the effect of compounds on hot flash symptoms
US20050064472A1 (en) * 2003-07-23 2005-03-24 Affymetrix, Inc. Methods of monitoring gene expression
DK2322278T3 (en) 2003-10-24 2017-04-10 Aushon Biosystems Inc Apparatus and method for dispensing liquid, semi-solid and solid samples
WO2005054438A2 (en) 2003-12-01 2005-06-16 Invitrogen Corporation Nucleic acid molecules containing recombination sites and methods of using the same
AR047574A1 (es) 2003-12-30 2006-01-25 Arborgen Llc 2 Genesis Res 1 Genes del ciclo celular y metodos de uso relacionados
US7598080B2 (en) 2004-08-20 2009-10-06 Carl Deirmengian Diagnostic assay for source of inflammation
FI20041204A0 (fi) 2004-09-16 2004-09-16 Riikka Lund Menetelmät immuunivälitteisiin sairauksiin liittyvien uusien kohdegeenien hyödyntämiseksi
US7799906B1 (en) 2004-09-22 2010-09-21 Arborgen, Llc Compositions and methods for modulating lignin of a plant
EP1704258B1 (de) 2004-11-18 2010-09-22 Eppendorf Array Technologies Echtzeit-pcr von zielen auf einem mikroarray
EP2522757A1 (de) 2005-02-18 2012-11-14 Monogram BioSciences, Inc. Verfahren und Zusammensetzungen zur Bestimmung der Suszeptibilität für Anti-HIV-Mittel und des HIV-Replikationsvermögens
US8178291B2 (en) 2005-02-18 2012-05-15 Monogram Biosciences, Inc. Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors
US20070072175A1 (en) * 2005-05-13 2007-03-29 Biogen Idec Ma Inc. Nucleotide array containing polynucleotide probes complementary to, or fragments of, cynomolgus monkey genes and the use thereof
CA2609910A1 (en) * 2005-05-27 2006-12-07 Monogram Biosciences, Inc. Methods and compositions for determining resistance of hiv-1 to protease inhibitors
WO2006133267A2 (en) 2005-06-06 2006-12-14 Monogram Biosciences, Inc. Methods and compositions for determining altered susceptibility of hiv-1 to anti-hiv drugs
WO2006133266A2 (en) 2005-06-06 2006-12-14 Monogram Biosciences, Inc. Methods for determining resistance or susceptibility to hiv entry inhibitors
EP1736780A1 (de) 2005-06-24 2006-12-27 Eppendorf Array Technologies S.A. Verfahren und Vorrichtungen zum Nachweis und/oder zur Quantifizierung hierarchischer, molekularer Veränderungen einer Zellantwort auf einen externen Stimulus
ATE548467T1 (de) * 2005-09-02 2012-03-15 Univ Toledo Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
DE602005005333T2 (de) 2005-09-13 2008-09-18 Eppendorf Array Technologies S.A. Verfahren zum Nachweis von homologen Sequenzen, welche sich durch eine Base unterscheiden, auf einem Mikroarray
US20070092903A1 (en) * 2005-10-24 2007-04-26 Fulmer-Smentek Stephanie B One-color microarray analysis methods, reagents and kits
AU2005239672B2 (en) * 2005-11-30 2009-06-11 Canon Kabushiki Kaisha Sortable collection browser
WO2007098065A2 (en) * 2006-02-17 2007-08-30 The United States Of America As Represented By The Department Of Veterans Affairs Human sodium channel isoforms
US20100070186A1 (en) * 2006-03-15 2010-03-18 Soper Bryan R Methods of screening for and mapping phenotypic and genotypic variations in cells
US7901882B2 (en) 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US8257929B2 (en) 2006-10-20 2012-09-04 University Of Miami Gene expression profiling of Parkinson's Disease
EP1935496A1 (de) 2006-12-22 2008-06-25 Eppendorf Array Technologies SA Vorrichtung und/oder Verfahren zur Detektion erweiterter Nukleotidsequenzen auf Mikro-Arrays
EP1961825A1 (de) 2007-02-26 2008-08-27 INSERM (Institut National de la Santé et de la Recherche Medicale) Verfahren zur Vorhersage des Auftretens von Metastasen bei Brustkrebspatienten
WO2008106115A2 (en) 2007-02-26 2008-09-04 Monogram Biosciences, Inc. Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy
EP2107125A1 (de) 2008-03-31 2009-10-07 Eppendorf Array Technologies SA (EAT) Echtzeit-PCR von Targets auf einem Mikroarray
US20110190662A1 (en) * 2008-10-01 2011-08-04 Beacon Endoscopic Corporation Rapid exchange fna biopsy device with diagnostic and therapeutic capabilities
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
RU2534891C2 (ru) 2009-12-29 2014-12-10 Хилл`С Пет Ньютришн, Инк. Композиции, содержащие имбирь, для облегчения или предотвращения воспалительных состояний
FI20105166A0 (fi) 2010-02-19 2010-02-19 Suomen Punainen Risti Veripalv Menetelmä kantasolupopulaation erilaistumistilan osoittamiseksi
EP2369325A1 (de) 2010-03-12 2011-09-28 Eppendorf Ag Arrayanalyse für Online-Detektion
WO2013043878A2 (en) 2011-09-20 2013-03-28 The George Washington University Alternative splicing variants of genes associated with prostate cancer risk and survival
US9988687B2 (en) 2011-09-20 2018-06-05 The George Washington Univeristy Companion diagnostics for cancer and screening methods to identify companion diagnostics for cancer based on splicing variants
AU2012367247B2 (en) 2012-01-24 2018-04-05 Cd Diagnostics, Inc. System for detecting infection in synovial fluid
EP2664619B1 (de) * 2012-05-16 2017-07-12 Manros Therapeutics Purinderivate als Werkzeuge zum Abtasten von Verbindungen gegen Alzheimer
WO2014047285A1 (en) 2012-09-19 2014-03-27 Paraskevi Giannakakou Identifying taxane sensitivity in prostate cancer patients
EP3736570A1 (de) 2019-05-09 2020-11-11 Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León Verfahren zur diagnose, subklassifizierung und prognose von akuter nierenverletzung durch detektion von cct7
WO2025171393A1 (en) * 2024-02-10 2025-08-14 New York Genome Center, Inc. Methods for drug target deconvolution

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8810400D0 (en) 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
ATE214633T1 (de) * 1993-10-28 2002-04-15 Houston Advanced Res Ct Mikrofabriziertes poröses durchflussgerät
WO1997027317A1 (en) 1996-01-23 1997-07-31 Affymetrix, Inc. Nucleic acid analysis techniques
JP2000504672A (ja) * 1996-02-09 2000-04-18 フィテラ シンビオン エイピーエス バラノール類似体
US5866702A (en) * 1996-08-02 1999-02-02 Cv Therapeutics, Incorporation Purine inhibitors of cyclin dependent kinase 2
US5965352A (en) 1998-05-08 1999-10-12 Rosetta Inpharmatics, Inc. Methods for identifying pathways of drug action

Also Published As

Publication number Publication date
DE69822206D1 (de) 2004-04-08
EP1040204A1 (de) 2000-10-04
EP1040204B1 (de) 2004-03-03
AU1926899A (en) 1999-07-12
WO1999032660A1 (en) 1999-07-01
US20010055771A1 (en) 2001-12-27
US6524800B2 (en) 2003-02-25
WO1999032660A9 (en) 1999-09-23
US6333155B1 (en) 2001-12-25
US20030180774A1 (en) 2003-09-25
DE69822206T2 (de) 2005-02-17

Similar Documents

Publication Publication Date Title
ATE260989T1 (de) Erkenntnisse der genomforschung für die suche nach neuartigen wirkstoffen
DK0675951T3 (da) Enzym med endoglucanaseaktivitet
DE69927046D1 (de) Vektoren für die gen-mutagenese und die entdeckung von genen durch 'gene-trapping'
IL180924A0 (en) Method for regulating cell proliferation and cell death
MX9800499A (es) Inhibicion de la expresion de genes.
ATE346156T1 (de) Umkehrtransfektionsverfahren
PT900279E (pt) Processo melhorado de transformacao de plantas
TR200002446T2 (tr) Fosfolipaz enzimlerinin inhibitörleri
DE69939056D1 (de) Vektoren für genmutagenese und genentdeckung
ES2195993T3 (es) Metodo para inhibir la produccion de etileno en plantas.
ATE213019T1 (de) Chimäre oligomere mit einer rns- spaltungsaktivität
DK1681355T3 (da) Sekvensspecifik DNA-rekombination i eukaryote celler
EP0832203A4 (de) Verwendung von neuronalen fötalen zellinien für die transplantationstherapie
MX9800500A (es) Inhibicion de la expresion de genes.
PT1141358E (pt) Ensaio para identificação de compostos que afectam a estabilidade do arnm
DE69012601D1 (de) Gentherapie durch stützgewebebezügliche Zellen.
DE69805627D1 (de) Verbesserte stämme für die protein-expression
EP0758681A3 (de) Hemmung der Transformation der Zellen mit erhöhter Purin-metabolischer Enzymaktivität
DE69941451D1 (de) Verfahren zur unterdrückung der genexpression in pflanzen
RU94043769A (ru) Способ повышения продукции протеина с, способ повышения уровня его модификации
TR200001960T2 (tr) Biyolojik ürünlerin üretimi için hücrelerin hazırlanması.
NO974367L (no) Vektorer samt fremgangsmåter for gen-ekspresjon i pattedyrceller
Dupont et al. Isolation and characterization of an uncoupler-resistant mutant of Saccharomyces cerevisiae.
WO2001023595A3 (en) Reduced gravity transformation process and product
Shugart et al. Poly (ADP-ribosylation) in N, N-diethylnitrosamine-treated mice.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties